Predictive biomarkers for latent Mycobacterium tuberculosis infection

被引:0
|
作者
Singh, Harinder [1 ]
Gonzalez-Juarbe, Norberto [1 ]
Pieper, Rembert [1 ]
Yu, Yanbao [1 ]
Vashee, Sanjay [1 ]
机构
[1] J Craig Venter Inst, Infect Dis & Genom Med Grp, 9605 Med Ctr Drive Suite 150, Rockville, MD 20850 USA
基金
美国国家卫生研究院;
关键词
RELEASE ASSAYS; DISEASE;
D O I
10.1016/j.tube.2023.102399
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tuberculosis is a leading cause of infectious death worldwide, with almost a fourth of the world's population latently infected with its causative agent, Mycobacterium tuberculosis. . Current diagnostic methods are insufficient to differentiate between healthy and latently infected populations. Here, we used a machine learning approach to analyze publicly available proteomic data from saliva and serum in Ethiopia's healthy, latent TB (LTBI) and active TB (ATBI) people. Our analysis discovered a profile of six proteins, Mast Cell Expressed Membrane Protein-1, Hemopexin, Lamin A/C, Small Proline Rich Protein 2F, Immunoglobulin Kappa Variable 4-1, and Voltage Dependent Anion Channel 2 that can precisely differentiate between the healthy and latently infected populations. This data suggests that combination of six host proteins can serve as accurate biomarkers to diagnose latent infection. This is important for populations living in high-risk areas as it may help in the surveillance and prevention of severe disease.
引用
收藏
页数:4
相关论文
共 50 条
  • [21] PREDICTIVE FACTORS OF MYCOBACTERIUM-TUBERCULOSIS INFECTION AND PULMONARY TUBERCULOSIS IN PRISONERS
    MARTIN SANCHEZ, V
    ALVAREZGUISASOLA, F
    CAYLA, JA
    ALVAREZ, JL
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1995, 24 (03) : 630 - 636
  • [22] Design and Development of Mycobacterium tuberculosis Lysine ε-Aminotransferase Inhibitors for Latent Tuberculosis Infection
    Parthiban, Brindha Devi
    Saxena, Shalini
    Chandran, Manoj
    Jonnalagadda, Padma Sridevi
    Yadav, Renu
    Srilakshmi, Rudraraju Reshma
    Perumal, Yogeeswari
    Dharmarajan, Sriram
    CHEMICAL BIOLOGY & DRUG DESIGN, 2016, 87 (02) : 265 - 274
  • [23] Extrapulmonary Locations of Mycobacterium tuberculosis DNA During Latent Infection
    Barrios-Payan, Jorge
    Saqui-Salces, Milena
    Jeyanathan, Mangalakumari
    Alcantara-Vazquez, Avissai
    Castanon-Arreola, Mauricio
    Rook, Graham
    Hernandez-Pando, Rogelio
    JOURNAL OF INFECTIOUS DISEASES, 2012, 206 (08): : 1194 - 1205
  • [24] Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaques
    Lin, Philana Ling
    Dartois, Veronique
    Johnston, Paul J.
    Janssen, Christopher
    Via, Laura
    Goodwin, Michael B.
    Klein, Edwin
    Barry, Clifton E., III
    Flynn, JoAnne L.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (35) : 14188 - 14193
  • [25] Fluoroquinolones for the treatment of latent Mycobacterium tuberculosis infection in liver transplantation
    Tiago Silva, Jose
    San-Juan, Rafael
    Fernandez-Ruiz, Mario
    Maria Aguado, Jose
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (26) : 3291 - 3298
  • [26] Comparative immune responses to Mycobacterium tuberculosis in people with latent infection or
    Jalbert, Emilie
    Liu, Cuining
    Mave, Vidya
    Lang, Nancy
    Kagal, Anju
    Valvi, Chhaya
    Paradkar, Mandar
    Gupte, Nikhil
    Lokhande, Rahul
    Bharadwaj, Renu
    Kulkarni, Vandana
    Gupta, Amita
    Weinberg, Adriana
    ISCIENCE, 2023, 26 (08)
  • [27] Prevalence of latent infection by Mycobacterium tuberculosis in renal transplant recipients
    Moreira Delgado Maciel, Monica Maria
    Ceccato, Maria das Gracas
    Carvalho, Wania da Silva
    de Navarro, Pedro Daibert
    Farah, Katia de Paula
    de Miranday, Silvana Spindola
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2018, 44 (06) : 461 - 468
  • [28] Guinea pig model of Mycobacterium tuberculosis latent/dormant infection
    Kashino, Suely S.
    Napolitano, Danielle R.
    Skobe, Ziedonis
    Campos-Neto, Antonio
    MICROBES AND INFECTION, 2008, 10 (14-15) : 1469 - 1476
  • [29] Serum antibody profiles in individuals with latent Mycobacterium tuberculosis infection
    Maekura, Ryoji
    Kitada, Seigo
    Osada-Oka, Mayuko
    Tateishi, Yoshitaka
    Ozeki, Yuriko
    Fujikawa, Takeya
    Miki, Mari
    Ogawa, Jyunnko
    Mori, Masahide
    Matsumoto, Sohkichi
    MICROBIOLOGY AND IMMUNOLOGY, 2019, 63 (3-4) : 130 - 138
  • [30] Fluoroquinolones for the treatment of latent Mycobacterium tuberculosis infection in liver transplantation
    Jose Tiago Silva
    Rafael San-Juan
    Mario Fernández-Ruiz
    José María Aguado
    World Journal of Gastroenterology, 2019, (26) : 3291 - 3298